Genetic analysis of azole resistance in the Darlington strain of Candida albicans

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 11, 2000, Pages 2985-2990

  Kakeya, H ^a   Miyazaki, Y ^a   Miyazaki, H ^a   Nyswaner, K ^a   Grimberg, B ^a   Bennett, J E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 ISOENZYME; FLUCONAZOLE; FUNGAL DNA; PYRROLE DERIVATIVE;

AMINO ACID SUBSTITUTION; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE; SITE DIRECTED MUTAGENESIS; SOUTHERN BLOTTING;

AMINO ACID SUBSTITUTION; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CHROMOSOMES, FUNGAL; CYTOCHROME P-450 ENZYME SYSTEM; DRUG RESISTANCE, MICROBIAL; FLUCONAZOLE; MICROBIAL SENSITIVITY TESTS; MUTAGENESIS, SITE-DIRECTED; OXIDOREDUCTASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE; TRANSFECTION;

EID: 0033753060     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.11.2985-2990.2000     Document Type: Article

References (26)

1. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance
2. Formation of azole-resistant Candida albicans by mutation of sterol 14-demethylase P450
3. Multiple amino acid substitutions in lanosterol 14α-demethylase contribute to azole resistance in Candida albicans
4. Isogenic strain construction and gene mapping in Candida albicans
5. Simplified isolation of chromosomal and plasmid DNA from yeast
6. Improved methods for high efficiency transformation of intact yeast cells
7. Inhibition of 14 alpha-sterol demethylase activity in Candida albicans Darlington does not correlate with azole resistance
8. A comparison of the sterol content of multiple isolates of the Candida albicans Darlington strain with other clinically azole-sensitive and resistant strains
9. CUG codons in Candida spp.
10. Transcriptional control of the yeast PDR5 gene by the PDR3 gene product
11. Nucleotide sequence of cytochrome P450 L1A1 (lanosterol 14 alpha-demethylase) from Candida albicans
12. The mutation T315A in Candida albicans sterol 14alpha-demethylase causes reduced enzyme activity and fluconazole resistance through reduced affinity
13. Molecular analysis of Cyp51 from fluconazole-resistant Candida albicans strains
14. Contribution of mutations in the cytochrome P450 14α-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans
15. Cloning, sequencing, expression and allelic sequence diversity of ERG3 (C-5 sterol desaturase gene) in Candida albicans
16. Restriction fragment length polymorprism analysis of azole-resistant and azole-susceptible Candida albicans strains
17. Amino acid substitutions in the cytochrome P-450 lanosterol 14 alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents
18. Mutation in cytochrome P450-dependent 14-demethylase results in decreased affinity for azole antifungals
19. Molecular and genetic analysis of URA5 transformants of Cryptococcus neoformans
20. Modified response to ketoconazole of Candida albicans from a treatment failure
21. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus
22. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14-α-demethylase in Candida albicans
23. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance
24. [URE3] as an altered URE2 protein: Evidence for a prion analog in Saccharomyces cerevisiae